| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Altrenogest (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Megestrol |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Dydrogesterone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethisterone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Norethisterone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Etynodiol diacetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Norgestrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Noretynodrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Desogestrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Hydroxyprogesterone |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Medroxyprogesterone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Flurogestone acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Norgestimate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Delmadinone acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Drospirenone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Norelgestromin (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Gestrinone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Allylestrenol (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Lynestrenol (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Etonogestrel (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Gestodene (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Gestonorone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Etynodiol |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Norgestomet (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| progestérone 50 mg/mL, ampoule de 2 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 40 mg/g vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 80 mg/g vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 200mg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 400mg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| progestérone 50 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Estradiol valerate 2 mg and norethisterone 700 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol+norethisterone 35micrograms/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 20mcg+progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 30mcg+progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 35mcg+progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ethinylestradiol 50mcg+progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing progesterone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Rectal/vaginal progesterone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Médicament progestatif |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
1 |
| Product containing progesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Estrogen-progestin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing melengestrol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Melengestrol acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 50mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 20mg topical cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Combined oestogen+progestogen preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Menstrual disorder comb.preps |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone - only contraceptives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 50mg/mL oil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Progesterone 100mg softgels (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Levonorgestrel 125microgram / Ethinylestradiol 30microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Levonorgestrel 50microgram / Ethinylestradiol 30microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Levonorgestrel 75microgram / Ethinylestradiol 40microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Nomegestrol (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Dienogest (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ulipristal (substance) |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Promegestone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Norethisterone acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Norethisterone enantate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Medroxyprogesterone acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Pregnanediolone |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Megestrol acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Hydroxyprogesterone caproate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Delmadinone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Ulipristal acetate (substance) |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Levonorgestrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Gestonorone caproate (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Segesterone acetate (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Segesterone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Nomegestrol acetate (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Medrogestone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| 46,XX disorder of sex development caused by synthetic oral progestogen (disorder) |
Causative agent (attribute) |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
1 |
| Oxendolone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Tibolone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
| Allylestrenol micronized (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]